Current shortage
OVIDREL choriogonadotropin alfa (rch) 250 microgram/ 0.5mL solution for injection pre-filled pen
Choriogonadotropin alfa · 250 microgram Injection, solution
- Supply impact started
- 1 July 2024
- Supply impact ends
- 31 Dec 2031
- TGA row last updated
- 6 Nov 2026
- ARTG ID
- 170446
- Sponsor
- Merck Healthcare Pty Ltd
- Sponsor phone
- 1800 257 348
- Shortage impact
- Critical
- Availability
- Limited Availability
Reason reported to TGA
Unexpected increase in demand due to other sponsors unable to supply
TGA management action
The sponsor is closely controlling the supply. An overseas-registered product has been approved for supply under section 19A. The approval holder, Merck Healthcare Pty Ltd, can be contacted for details on supply on 1800 633 463.
What to do
- 1.Contact your pharmacist — Your pharmacist can check stock and whether another pharmacy can supply this product.
- 2.Ask your doctor before switching — A prescriber can decide whether another product is appropriate. Do not change medicines on your own.
- 3.Check the TGA report — The TGA Medicine Shortage Reports Database is the source for the dates and management action on this page.
Official sources
Last updated from the TGA Medicine Shortage Reports Database (report generated 12 November 2026 10:24:39 PM).
MedWatch is for informational purposes only and does not constitute medical advice. Never stop or change your medicines without consulting your doctor or pharmacist. In an emergency, call 000. Medication queries: National Medicines Line 1300 633 424.